Pulmonary Tuberculosis I
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Pulmonary Tuberculosis V
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Jingru Cheng1, Ruina Chen1, Hongqiu Pan2
1Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.
Anti-tuberculosis drug-induced liver injury (ATLI) is a major concern. A machine learning model using eight clinical factors accurately predicts ATLI risk, aiding early detection in tuberculosis patients.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: